Registry for patients with coronary artery disease treated with NIRS-IVUS
Korean Near-infrared Spectroscopy(NIRS)-Intravascular Ultrasound (IVUS) Multicenter Registry: a Comprehensive Study
This study collects information from patients with coronary artery disease who have had a specific heart procedure to see how well it works and how it helps them recover.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1500 (estimated) |
| Ages | 19 Years and up |
| Sex | All |
| Sponsor | Korea University Anam Hospital Academic / other |
| Locations | 1 site (Seoul) |
| Trial ID | NCT04619355 on ClinicalTrials.gov |
What this trial studies
This observational registry collects data on patients with coronary artery disease who have undergone percutaneous coronary intervention (PCI) using Near-Infrared Spectroscopy Intravascular Ultrasound (NIRS-IVUS). The study aims to evaluate the effectiveness and outcomes of this diagnostic and treatment approach in managing coronary artery disease, particularly in cases of myocardial infarction. By gathering clinical data and follow-up information, the registry seeks to enhance understanding of patient responses and improve future treatment protocols.
Who should consider this trial
Good fit: Ideal candidates include patients who have undergone PCI using NIRS-IVUS and have consented to participate in the study.
Not a fit: Patients who cannot undergo cardiovascular angiography due to severe heart failure or have a life expectancy of less than one year due to other diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this registry could lead to improved diagnostic and treatment strategies for patients with coronary artery disease.
How similar studies have performed: While this approach is observational, similar studies using advanced imaging techniques in coronary artery disease have shown promising results.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patient who underwent PCI using NIRS-IVUS * Subjects who agreed to the study plan and clinical follow-up plan, voluntarily decided to participate in this clinical study and agreed in writing to the subject consent form Exclusion Criteria: * Subjects who cannot perform cardiovascular angiography due to severe symptoms of heart failure * Subjects whose expected life expectancy is within 1 year due to the accompanying disease * Women of childbearing age who plan to become pregnant within the study period
Where this trial is running
Seoul
- Korea University Anam Hospital — Seoul, South Korea (Recruiting)
Study contacts
- Principal investigator: Soon Jun Hong, MD, PhD — Korea University Anam Hospital
- Study coordinator: Jung Joon Cha, MD,PhD
- Email: joonletter@hanmail.net
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.